CEFPROX-200

CEFPROX-200 contains Cefpodoxime, a third-generation cephalosporin antibiotic used for the treatment of a wide range of bacterial infections. It is commonly prescribed in both outpatient and hospital settings due to its dependable activity against many Gram-positive and Gram-negative organisms.In routine clinical practice, infections affecting the respiratory tract, urinary tract, and skin are frequently encountered and require timely and appropriate treatment. CEFPROX-200 helps manage these conditions by controlling bacterial growth and limiting the spread of infection. By supporting the body’s natural healing response, it contributes to steady recovery. Its consistent clinical performance and broad antibacterial coverage make it a practical and reliable choice for physicians.

Mechanism of Action

Cefpodoxime inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins (PBPs) which play a key role in the formation of the bacterial cell wall. By interfering with this process, it prevents proper development of the cell wall structure, making it weak and unstable.This leads to cell lysis and ultimately the death of the bacteria. Its bactericidal action helps reduce the bacterial load, control the spread of infection, and supports effective and timely clinical recovery.

Indications

CEFPROX-200 is indicated for the treatment of:

• Respiratory tract infections, including bronchitis and pneumonia
• Urinary tract infections
• Skin and soft tissue infections
• Ear, nose, and throat (ENT) infections such as sinusitis and tonsillitis
• Other susceptible bacterial infections

Key Benefits

• Broad-spectrum antibacterial activity
• Effective against both Gram-positive and Gram-negative organisms
• Helps deliver consistent and reliable clinical results
• Suitable for use in common as well as moderately severe infections
• Well-established and widely used antibiotic in clinical practice

Dosage and Administration

CEFPROX-200 should be used under the supervision of a qualified healthcare professional. The dosage and duration of therapy depend on the type and severity of the infection, as well as the patient’s overall condition and response to treatment.It is important to complete the full prescribed course, even if symptoms improve earlier. This helps ensure complete eradication of the infection and reduces the risk of recurrence or development of resistance.

Why Choose CEFPROX-200?

CEFPROX-200 offers a dependable and practical solution for managing bacterial infections. With a well-established molecule and a proven clinical track record, it delivers consistent performance across a variety of treatment settings.Its broad antibacterial coverage and predictable response make it suitable for both routine infections and moderately severe cases. Manufactured under stringent quality standards, it ensures safety, efficacy, and uniformity in every dose. For healthcare professionals, CEFPROX-200 remains a reliable and trusted choice for effective infection management.